Related Experiment Video
Updated: Jan 26, 2026

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model
Published on: August 11, 2023
Recanalization treatments in basilar artery occlusion-Systematic analysis
Perttu J Lindsberg1,2, Tiina Sairanen1, Simon Nagel3
1Clinical Neurosciences, Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Endovascular mechanical approaches improve outcomes for basilar artery occlusion stroke compared to pharmacological thrombolysis. Careful patient selection, excluding those with extensive ischemia, is crucial for better clinical results.
Area of Science:
- Neurology
- Interventional Neuroradiology
- Stroke Medicine
Background:
- Basilar artery occlusion (BAO) is a severe stroke type requiring revascularization.
- Current treatments include pharmacological thrombolysis and endovascular thrombectomy.
- The optimal approach and reasons for treatment futility remain unclear.
Purpose of the Study:
- To compare the effectiveness of endovascular mechanical interventions versus pharmacological thrombolysis for BAO.
- To identify predictors of futile recanalization in BAO treatment.
Main Methods:
- Systematic review and meta-analysis of 15 reports (2005 onwards) involving 803 patients.
- Analysis of a large single-center cohort (162 patients) to determine futility predictors.
Main Results:
- Mechanical approaches yielded better outcomes (35.5% vs. 24.4%) and recanalization rates (84.1% vs. 70.9%) than pharmacological thrombolysis.
- Primary thrombectomy achieved 91% recanalization and 36% good outcomes, but with a 60% futility rate (reduced to 52.8% with stentrievers).
- Extensive baseline ischemia was the strongest predictor of futile recanalization (OR 20-fold).
Conclusions:
- Endovascular mechanical methods offer superior outcomes for BAO compared to pharmacological thrombolysis.
- Improved patient selection, particularly avoiding those with extensive ischemia, is vital for enhancing clinical outcomes and reducing futility rates.
More Related Videos
06:54A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
07:19Recording of Inward Rectifying K+ Currents in Freshly Isolated Basilar Artery Smooth Muscle Cells by Patch Clamp Technique
Published on: February 7, 2025
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Random and Systematic Errors
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...